/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | DLBDolby Laboratories, |
|---|---|
| Last close | $64.79close 2026-11-09 |
| Change % | -0.06%close 2026-11-09 |
| Market cap | $6.1Bclose 2026-11-09 |
| P/E | 24.7FY to 2025-09-26 |
| Revenue | $1.3B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 5.9%FY to 2025-09-26 |
| Net income | $255M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-09-26 Filing10-K · 0001308547-25-000007 · filed 2025-11-18 Open the filing on EDGAR →Open the XBRL payload →CiteDolby Laboratories, Inc. (DLB), us-gaap:NetIncomeLoss: 255,018,000 USD, fiscal year ended 2025-09-26. Form 10-K, accession 0001308547-25-000007, filed 2025-11-18. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001308547/us-gaap/NetIncomeLoss.json |
| Net margin | 18.9%FY to 2025-09-26 |
| EPS (diluted) | $2.62⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-09-26 Filing10-K · 0001308547-25-000007 · filed 2025-11-18 Open the filing on EDGAR →Open the XBRL payload →CiteDolby Laboratories, Inc. (DLB), us-gaap:EarningsPerShareDiluted: 2.62 USD per share, fiscal year ended 2025-09-26. Form 10-K, accession 0001308547-25-000007, filed 2025-11-18. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001308547/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 5FY to 2025-09-26 |
| Altman Z-ScoreUNVALIDATED | 8.35FY to 2025-09-26 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 11-12 → 11-22 |